|
Market Closed -
OTC Markets
13:01:27 2026-06-03 EDT
|
5-day change | 1st Jan Change | ||
| 0.0169 USD | +141.43% |
|
-.--% | +4.00% |
| 05-27 | Acrux licenses Lenzetto for Australian market for A$5.4 million | RE |
| 05-27 | Hungary's Richter and Acrux agree to license transdermal estradiol spray for Australia | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACRUX LIMITED | Generic Pharmaceuticals | +141.43% | -.--% | +4.00% | +111.25% | -79.20% | 4.18M |
-
|
-
|
-
|
- Stock Market
- Stocks
- ACR Stock
- ARUXF Stock
- Charts Acrux Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
